There is a problem in the importation of diagnostic sera from outside the United States to research institutions within this country, as well as in the movement of sera from place to place in the United States. In maximal safety installations, such as this laboratory, the movement of sera from section to section becomes difficult. The problem common to these situations is the possible inclusion of an active viral agent in the serum. Ibertini et al. (Schweiz. Arch. Tierheilk. 99:309, 1957) have shown that ,B-propiolactone (BPL) will inactivate foot-and-mouth disease virus (FMDV), and Stone and DeLay (J. Immunol. 87:464, 1961) have found that BPL will inactivate rinderpest virus in serum. In the present study, FMDV antiserum was deliberately contaminated with a heterologous type of FMDV, and samples of the serum were treated with various concentrations of BPL at 28 C for 30 min.
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Guinea pig sera containing neutralizing antibodies against type 0, strain 1 virus were intentionally contaminated with type A, strain 119 virus in its 90th tissue culture passage in a concentration of 105 mouse LD5o per 0.05 ml of serum. After adjustment of serum to pH 8.0, BPL was added to make concentrations of 0.5, 0.3, and 0.05% by volume in separate samples. While the mixtures of BPL and serum were being heated at 28 C for 30 min, the pH was maintained at 8.0. At the end of this period, samples of the treated serum were taken for assay of surviving virus in suckling mice (Table 1) .
Treated and untreated sera were heated at 56 C for 30 min, and a virus-neutralization test was conducted with serial 10-fold dilutions of type 0, strain Ml1 virus in its 23rd tissue culture passage. The dilutions of virus were mixed with a fixed dilution of serum. Mixtures of virus and serum were incubated for 1 hr at 37 C prior to inoculation into suckling mice, ten mice per dilution.
The neutralization indices for two different sera, The preliminary incubation period was for 18 hr at 4 C, after which the sensitized cells were added and another incubation period for 30 min at 37 C was accomplished. Two different FMDV antisera were used, one of high titer and one of median titer. The results appear in Table 3 .
Contaminating virus was not detected by use of mouse-infectivity assay with sera treated with 0.5 or 0.3% BPL, but was apparent in serum treated with 0.05% BPL. The neutralization indices displayed no differences between treated and untreated sera greater than 1 log of activity. In the complement-fixation test, the loss in titer of serum treated with 0.5% BPL was fivefold, whereas the loss occasioned by treatment with 0.3% BPL was threefold. The least amount of BPL capable of inactivating the virus in the antiserum and most conserving of antibody titer appeared to be a concentration of 0.3%. Even at a higher temperature of 37 C, with lower concentrations of BPL (0.2, 0.1%) in a medium containing less protein than serum, 0.3% content of the inactivant was necessary to destroy the virus as tested in steers (Fellowes et al., Am. J. Vet. Res. 20:992, 1959) .
